ChatYou are Viewing our Top Doctor

ChatChat on WhatsApp

About Dr. Sameer A. Tulpule

Dr. Sameer Tulpule is a leading Haematologist and BMT expert in India with a profound experience in treating a wide spectrum of blood disorders and cancers. With extensive training and practice in prestigious UK hospitals, he brings a global standard of care to India. Dr. Tulpule is regarded as one of the leading haematologists in India, renowned for his deep expertise in complex procedures like Bone Marrow Transplantation (Autologous, Allogeneic, and Haploidentical) and the revolutionary CAR-T Cell Therapy. His clinical focus includes managing acute and chronic leukaemias, multiple myeloma, and lymphomas. His commitment to blending advanced therapies with compassionate patient care makes him one of the top BMT specialists in Mumbai.

OPD Schedule Of Dr. Sameer A. Tulpule

Consultation Fees Rs. 2000 /-
Kokilaben Dhirubhai Ambani Hospital, Mumbai
MON 09:00 AM - 08:00 PM
TUE 09:00 AM - 08:00 PM
WED 09:00 AM - 08:00 PM
THU 09:00 AM - 08:00 PM
FRI 09:00 AM - 08:00 PM
SAT 09:00 AM - 08:00 PM
ChatWhatsApp

Medical Degrees
  • MBBS: Seth G.S. Medical College & K.E.M. Hospital, University of Mumbai (1993)
  • MD (Medicine): Jawaharlal Nehru Medical College & KLES Hospital, Rajiv Gandhi University of Health Sciences, Bangalore (1999)
Fellowships & Special Training
  • Fellow (Post-CCT) – Bone Marrow Transplant: Nottingham University Hospitals NHS Trust, UK (2013)
  • Research Fellow – Stem Cell Transplant: Anthony Nolan Trust, London, UK (2009 - 2011)
Certifications & Accreditations
  • FRCPath (Haematology): Royal College of Pathologists, UK (2011)
  • MRCP: Royal College of Physicians, UK (2004)

Major Cancer Types Treated
  • Acute & Chronic Leukaemias
  • Multiple Myeloma
  • Lymphomas
Sub-specialties
  • Haemato-Oncology
  • Benign Haematology
  • Anaemia (including Thalassaemia)
  • Polycythaemia
  • Platelet & White Cell Disorders
  • Bleeding & Clotting Disorders
Advanced Procedures Performed
  • Bone Marrow Transplantation (Autologous, Allogeneic & Haploidentical)
  • CAR-T Cell Therapy
  • Stem Cell Transplantation
  • Targeted Therapies for Lymphoma and Myeloma

Current Affiliation:
  • Senior Director – Haematology & BMT: Nanavati Max Super Speciality Hospital, Mumbai
Past Affiliations:
  • Consultant – Haematology & Stem Cell Transplantation: Kokilaben Dhirubhai Ambani Hospital, Mumbai
  • Consultant – Haematology: Sheffield Teaching Hospitals NHS Foundation Trust, UK
  • Locum Consultant – Haematology: Northwick Park Hospital, NWLH NHS Trust, London
Academic & Research Roles
  • Fellow (Post-CCT) – Bone Marrow Transplant: Nottingham University Hospitals NHS Trust, UK (Apr 2013 - Oct 2013)
  • Medical Officer & Research Fellow – Stem Cell Transplant: Anthony Nolan Trust, London (Aug 2009 - Aug 2011)
Key Achievements & Contributions
  • Extensive experience working within the UK’s National Health Service (NHS), bringing international protocols and standards of care to his practice in India.
  • Specialised training and research in stem cell transplantation from leading UK centres.
  • Holds prestigious qualifications from the Royal College of Physicians and the Royal College of Pathologists, UK.
  • Actively involved in research and has co-authored numerous publications in high-impact international journals.

  • “Best Outgoing Resident” in Medicine – 4th Karnataka State Conference, API & CSI
  • Second rank in MBBS, University of Bombay
  • University distinctions in Pathology & Pharmacology

Published Papers in Medical Journals
  • Standardisation and Validation of PCR Fragment Analysis-Based Assay for Detection of Mixed Donor Chimerism in Haematopoietic Stem Cell Transplant Recipients (Canadian Journal of Biotechnology, 2017)
  • Rejection of Paternal vs Maternal Fully Matched Bone Marrow Grafts in Children with Thalassaemia (2017)
  • A Multicentre Retrospective UK Study Detailing Onset of Graft Versus Host Disease… Following Haematopoietic Stem Cell Transplantation (2015)
  • Subsequent Donation Requests Among 2472 Unrelated Hematopoietic Progenitor Cell Donors Are Associated with Bone Marrow Harvest (2013)
  • Immune Reconstitution in Cord Blood Transplantation (CML, Leukemia & Lymphoma, 2011)
  • Severe Allergic Reaction with Anaphylaxis to G-CSF (Lenograstim) in a Healthy Donor (2009)
  • Management and Outcome of Four Pregnancies in Women with Idiopathic Myelofibrosis (British Journal of Haematology, 2008)
  • Safety and Efficacy of Mycophenolate Mofetil in Relapsing Acquired Thrombotic Thrombocytopenic Purpura (ASH Abstract, 2006)

Patient Testimonials
  • "Dr. Sameer Tulpule is a phenomenal doctor. When my father was diagnosed with Acute Leukaemia, we were devastated. Dr. Tulpule's calm demeanour, clear explanations, and world-class treatment plan for the bone marrow transplant gave us hope. He is not just a doctor but a true guide. We are forever grateful." - Priya S., Mumbai
  • "My journey through Multiple Myeloma was challenging, but having Dr. Tulpule made all the difference. His knowledge of the latest targeted therapies is exceptional. He is empathetic, patient, and always accessible. I highly recommend him to anyone seeking the best haematology care in India." - Rohan Mehra, Delhi
  • "As an international patient from the UAE, I was looking for the best BMT facility in India. Dr. Tulpule and his team were outstanding. The entire process, from virtual consultation to post-transplant care, was seamless through Cancer Rounds. His expertise is truly top-tier." - Fatima, Dubai

  • Patient-Centred Care
Dr. Tulpule follows a deeply patient-centric approach, ensuring that patients and their families are active participants in the treatment journey. He believes in clear, honest communication and providing comprehensive information to empower them to make informed decisions.
  • Technology & Innovation
With a strong foundation in both UK and Indian healthcare systems, Dr. Tulpule is at the forefront of adopting medical innovations. He is a strong proponent of using advanced diagnostics and novel treatments like CAR-T Cell Therapy and targeted agents to achieve the best possible outcomes while minimising toxicity. His practice is rooted in evidence-based medicine, combining cutting-edge research with extensive clinical experience.

The cost of treatment can vary significantly based on the specific diagnosis, the type of procedure, hospital stay duration, and the patient's overall health. A general overview is provided below:
Treatment / ProcedureEstimated Cost (in INR)Estimated Cost (in USD)
Autologous Bone Marrow Transplant (BMT)₹15,00,000 - ₹20,00,000$18,000 - $24,000
Allogeneic Bone Marrow Transplant (BMT)₹25,00,000 - ₹40,00,000$30,000 - $48,000
Haploidentical Bone Marrow Transplant₹30,00,000 - ₹50,00,000$36,000 - $60,000
CAR-T Cell Therapy₹3,00,00,000 - ₹4,00,00,000$360,000 - $480,000
Note: The costs are approximate.For consultation, you can connect with the Cancer Rounds team.

The Cancer Rounds team provides comprehensive support for international patients seeking treatment with Dr. Tulpule.
  • Language Support: Professional interpreters for various languages are available to ensure clear communication.
  • Visa & Travel Assistance: The team assists with visa invitation letters, airport transfers, local travel, and accommodation arrangements for the patient and their attendants.
  • Pre-treatment Virtual Consultations: Dr. Tulpule is available for pre-treatment virtual consultations to review medical records, provide a second opinion, and formulate a preliminary treatment plan before the patient travels to India.

Frequently Asked Questions

Dr. Sameer Tulpule specialises in adult haematology and bone marrow transplantation. His key areas of focus include blood cancers like leukaemia, lymphoma, and multiple myeloma, as well as complex benign blood disorders like thalassaemia, anaemia, and clotting disorders.

Yes, with extensive training from the UK and over 16 years of experience, Dr. Sameer Tulpule is considered one of the top bone marrow transplant specialists in India. He is proficient in all forms of BMT, including autologous, allogeneic, and haploidentical transplants.

CAR-T cell therapy is a groundbreaking immunotherapy where a patient's own immune cells (T-cells) are genetically engineered to fight cancer. Dr. Tulpule has a special interest and expertise in this advanced procedure, making him one of the key physicians for this treatment in India.

His work in the UK's NHS and with premier research institutions like the Anthony Nolan Trust means he brings a wealth of international experience, adherence to stringent treatment protocols, and exposure to the latest global advancements in haematology and BMT to his patients in India.

Dr. Tulpule is experienced in managing all forms of leukaemia in adults, including Acute Myeloid Leukaemia (AML), Acute Lymphoblastic Leukaemia (ALL), Chronic Myeloid Leukaemia (CML), and Chronic Lymphocytic Leukaemia (CLL).

Choosing Dr. Tulpule means you are under the care of a leading haematologist in Mumbai who combines international qualifications (FRCPath, MRCP UK), vast experience in complex procedures like BMT and CAR-T therapy, and a patient-first approach.

Absolutely. Dr. Tulpule frequently consults and treats international patients. The Cancer Rounds team facilitates the entire process, including virtual consultations, travel, and accommodation, ensuring a smooth experience.

You can easily book an appointment with Dr. Sameer Tulpule by contacting the Cancer Rounds team. They will assist you with scheduling a physical or virtual consultation.